SignalXSignalX

MIRM Mirum Pharmaceuticals, Inc.

8-K Current Report
Filed: February 25, 2026
Health Care
Pharmaceutical Preparations
Mirum Pharmaceuticals, Inc. Overview

Mirum Pharmaceuticals, Inc. (MIRM) 8-K current report filed with SEC EDGAR on February 25, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

  • Item 2.02: Results of Operations and Financial Condition

AI Filing Analysis
8-K

Item 2.02 · Results of Operations and Financial Condition

  • • Q4 and full-year 2025 earnings release issued Feb 25, 2026 — full financials in Exhibit 99.1
  • • Filing covers period ended Dec 31, 2025 — key metrics, guidance, and pipeline updates expected in press release
+1 more insights

Get deeper insights on Mirum Pharmaceuticals, Inc.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.